Radiat Oncol J.  2016 Jun;34(2):81-87. 10.3857/roj.2016.01697.

Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery

Affiliations
  • 1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea. radiat@snu.ac.kr
  • 2Department of Radiation Oncology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

Abstract

Hypofractionated whole breast irradiation (HF-WBI) has been proved effective and safe and even better for late or acute radiation toxicity for early breast cancer. Moreover, it improves patient convenience, quality of life and is expected to be advantageous in the medical care system by reducing overall cost. In this review, we examined key randomized trials of HF-WBI, focusing on adequate patient selection as suggested by the American Society of Therapeutic Radiology and Oncology (ASTRO) guideline and the radiobiologic aspects of HF-WBI in relation to its adoption into clinical settings. Further investigation to identify the current practice pattern or cost effectiveness is warranted under the national health insurance service system in Korea.

Keyword

Breast neoplasms; Radiotherapy; Dose hypofractionation

MeSH Terms

Breast Neoplasms*
Breast*
Cost-Benefit Analysis
Dose Hypofractionation
Humans
Korea
Mastectomy, Segmental*
National Health Programs
Patient Selection
Quality of Life
Radiation Oncology
Radiotherapy
Full Text Links
  • ROJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr